Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jul 23;14(1):26. doi: 10.1186/1470-7330-14-26

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014 Souza et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

56 year old female with NSCLC treated with Bevacizumab. A-B. Computed tomography and PET-CT demonstrating soft tissue mass in the right middle lobe extending to the right hilar region demonstrating significantly increased tracer uptake. C-D. After 2 cycles of Bevacizumab (Avastin) there has been interval development of pulmonary cavitation within the central portion of the RML mass. PET-CT showing central cavitation and decrease in FDG uptake in the central portion of the mass (arrow). Persistent peripheral soft tissue and right hilar adenopathy are seen.